Prognostic significance of copy number alterations in adolescent and adult patients with precursor B acute lymphoblastic leukemia enrolled in PETHEMA protocols. (Q53831155)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Prognostic significance of copy number alterations in adolescent and adult patients with precursor B acute lymphoblastic leukemia enrolled in PETHEMA protocols.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26194343%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Prognostic significance of copy number alterations in adolescent and adult patients with precursor B acute lymphoblastic leukemia enrolled in PETHEMA protocols (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26194343%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

1 reference

based on heuristic

inferred from title

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

Mireia Morgades

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26194343%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26194343%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26194343%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26194343%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Joaquin Martinez-Lopez

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26194343%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Jesus Maria Hernandez Rivas

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26194343%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Eulàlia Genescà

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26194343%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

author name string

Jordi Ribera

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26194343%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Pau Montesinos

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26194343%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Inés Gómez-Seguí

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26194343%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Marta Pratcorona

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26194343%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Josep Sarrà

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26194343%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Ramon Guàrdia

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26194343%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

José González-Campos

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26194343%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Pere Barba

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26194343%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Lourdes Escoda

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26194343%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Francesc Solé

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26194343%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Fuensanta Millá

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26194343%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Evarist Feliu

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26194343%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Josep-Maria Ribera

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26194343%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Spanish PETHEMA Group and the Spanish Society of Hematology

21

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26194343%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

language of work or name

0 references

publication date

20 July 2015

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26194343%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26194343%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

121

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26194343%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

21

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26194343%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

3809-3817

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26194343%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

A revised definition for cure of childhood acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29579

21 January 2018

Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29579

21 January 2018

Acquisition of genome-wide copy number alterations in monozygotic twins with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29579

21 January 2018

Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29579

21 January 2018

Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29579

21 January 2018

Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29579

21 January 2018

What is the relevance of Ikaros gene deletions as a prognostic marker in pediatric Philadelphia-negative B-cell precursor acute lymphoblastic leukemia?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29579

21 January 2018

Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29579

21 January 2018

IGH@ translocations, CRLF2 deregulation, and microdeletions in adolescents and adults with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29579

21 January 2018

CDKN2A/B alterations impair prognosis in adult BCR-ABL1-positive acute lymphoblastic leukemia patients.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29579

21 January 2018

IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29579

21 January 2018

Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29579

21 January 2018

Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the Programa Español de Tratamiento en Hematología pediatric-based protocol ALL-96.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29579

21 January 2018

Genes commonly deleted in childhood B-cell precursor acute lymphoblastic leukemia: association with cytogenetics and clinical features

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29579

21 January 2018

Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29579

21 January 2018

A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29579

21 January 2018

The transcriptional regulation of B cell lineage commitment.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29579

21 January 2018

Outcomes of children with BCR-ABL1–like acute lymphoblastic leukemia treated with risk-directed therapy based on the levels of minimal residual disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29579

21 January 2018

Comprehensive analysis of CDKN2A status in microdissected urothelial cell carcinoma reveals potential haploinsufficiency, a high frequency of homozygous co-deletion and associations with clinical phenotype.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29579

21 January 2018

Breakpoint-specific multiplex polymerase chain reaction allows the detection of IKZF1 intragenic deletions and minimal residual disease monitoring in B-cell precursor acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29579

21 January 2018

Evaluation of multiplex ligation-dependent probe amplification as a method for the detection of copy number abnormalities in B-cell precursor acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29579

21 January 2018

Poor prognosis for P2RY8-CRLF2 fusion but not for CRLF2 over-expression in children with intermediate risk B-cell precursor acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29579

7 January 2021

based on heuristic

inferred from DOI database lookup

Hemizygous p16(INK4A) deletion in pediatric acute lymphoblastic leukemia predicts independent risk of relapse

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29579

7 January 2021

based on heuristic

inferred from DOI database lookup

CDKN2 deletions have no prognostic value in childhood precursor-B acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29579

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic significance of complex karyotype and monosomal karyotype in adult patients with acute lymphoblastic leukemia treated with risk-adapted protocols

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29579

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of High-Risk Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia in Adolescents and Adults According to Early Cytologic Response and Minimal Residual Disease After Consolidation Assessed by Flow Cytometry: Final Results of the P

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29579

7 January 2021

based on heuristic

inferred from DOI database lookup

CDKN2A deletions in acute lymphoblastic leukemia of adolescents and young adults—An array CGH study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29579

7 January 2021

based on heuristic

inferred from DOI database lookup

Hypermethylation of p16 and p15 genes and RB protein expression in acute leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29579

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53831155&oldid=1586507238"